Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2017, Vol. 44 Issue (4): 524-527    DOI: 10.12891/ceog3429.2017
Original Research Previous articles | Next articles
Morbidly adherent placenta previa: clinical course and risk from emergency delivery in a series of 26 women that underwent hysterectomy
H. Alchalabi1, *(), Y.S. Khader2, I. Lataifeh1, B. Obeidat1, F. Zayed1, W. Khriesat3, N. Obeidat1
1 Department of Obstetrics and Gynecology, Community Medicine and Family Medicine, Jordan University of Science and Technology, Irbid, Jordan
2 Department of Public Health, Community Medicine and Family Medicine, Jordan University of Science and Technology, Irbid, Jordan
3 Department of Pediatrics, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  Objectives: A retrospective review of morbidly adherent placenta previa (MAPP) to assess its clinical course and risk from emergency delivery. Study design: Data of all placenta previa (PP) delivered in this hospital over a period of >ten years were obtained from hospital register. Results: 91 women included, 26 MAPP and 65 PP. Emergent delivery and delivery for hemorrhage were significantly lower in MAPP (p = 0.033 and 0.046 respectively). In those beyond 35 weeks, one MAPP and 16 PP needed emergent delivery (p = 0.015). MAPP who needed emergent delivery had higher rate of bleeding during pregnancy and bleeding before 32 weeks (p= 0.034 and 0.01 respectively). Complications rate in MAPP were similar in emergency and elective delivery but for postoperative hospital stay (p = 0.042). All neonates delivered at ≤ 34 weeks and two out of six delivered at 35-36 weeks and admitted to NICU. Conclusion: The authors conclude that in this study group majority of MAPP were stable and emergent deliveries had more frequent history of bleeding before 32 weeks. Timing of delivery should take into consideration history of bleeding and availability of NICU resources in stable patients.
Key words:  Morbidly adherent placenta previa      Placenta previa      Late preterm delivery      Perinatal outcome     
Published:  10 August 2017     
*Corresponding Author(s):  H. ALCHALABI     E-mail:  halchalabi@yahoo.com

Cite this article: 

H. Alchalabi, Y.S. Khader, I. Lataifeh, B. Obeidat, F. Zayed, W. Khriesat, N. Obeidat. Morbidly adherent placenta previa: clinical course and risk from emergency delivery in a series of 26 women that underwent hysterectomy. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(4): 524-527.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog3429.2017     OR     https://ceog.imrpress.com/EN/Y2017/V44/I4/524

[1] J.Y. Yan, P.P. Chen, L.L. Jiang, H.L. Zhang, Q. Han, R.X. Chen, Q.J. Zhang. Exploration on the relationship between hypoxia inducible factor-1α and morbidly adherent placenta[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(4): 565-570.
[2] S. Y. Jung, S. J. Chon, R. S. Lee, E. Y. Woo, J. S. Lee, S. Y. Kim. Difference in pregnancy outcomes between primiparous and multiparous women older than 40 years[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 243-247.
[3] K. Relakis, A. Pontikaki, I. Kosmas, S. Sifakis. Bilateral ascending uterine arteries ligation for conservative management of complete placenta previa: three case reports[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 144-146.
[4] N. Al-Husban, O. Al-Kuran, M. Khadra, K. Fram. Thrombocytopenia in pregnancy; prevalence, causes and fetomaternal outcome[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 21-26.
[5] H. Takahashi, Y. Baba, M. Ogoyama, H. Suzuki, A. Ohkuchi, R. Usui, S. Matsubara. Does previous cesarean section per se, especially its number, increase the risk of allogeneic blood transfusion at cesarean section for placenta previa?[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 41-46.
[6] M.L. Kozakiewicz, J.F. Nitsche, P.W. Whitecar, B.C. Brost. En bloc hysterectomy for treatment of symptomatic cervical varix in the early second trimester[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(4): 661-662.
[7] F. Thekrallah, A. Alnadi, A. Almajalii, N. Muhaidat, A. Al-qatawneh, E.F. Badran. Obstetrics and perinatal outcome of grand multiparity in Jordan: a case-control study[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(2): 250-257.
[8] S. Obata, S. Aoki, K. Sakamaki, K. Seki, F. Hirahara. Perinatal outcome of prolonged preterm premature rupture of membranes near the limit of fetal viability[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 16-20.
[9] X.W. Sun, X.M. Bai, Q. Chen, J.F. Shen, L. Yang, J.Y. Zhang, X.S. Gu, Q. Yuan, J. Jing, Y. Jin. Preset catheter sheaths for uterine arterial embolization in the cesarean section of pernicious preplacental placenta: its application[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 108-112.
[10] M.S. Beksac, N.K. Ertürk, A.T. Beksac, G. Örgül, H.T. Celik, M. Yurdakök, T. Yildirim, A. Dolgun. Primary glomerular diseases and pregnancy[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(5): 682-686.
[11] Tao Cui, Yiqi Zhao, Wenli Zhang, Qiang Yao. Uterine prolapse with complete placenta praevia and umbilical hernia in pregnancy: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 602-604.
[12] N. Peker, A. Demir, C. Aydın, A. Biler, S. Gundogan. Adolescent pregnancies and perinatal outcomes: a study at tertiary hospital at the eastern part of Turkey[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 339-343.
[13] K. Roloff, A. Gray, V.J. Guillermo. Repeat cesarean delivery in the 39-week rule era: outcomes at a community based hospital[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 391-395.
[14] A. Okada, K. Tanaka, K. Kajitani, S. Nishimoto, H. Nakamura, O. Nakamoto. Near-infrared spectroscopy during cesarean section with common iliac artery balloon occlusion for total placenta previa: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 112-114.
[15] E. Cakar, N. Tarhan, H.A. Taşan, D. Karcaaltincaba, M.B. Sentürk, Ç.A. Yayla, A.A. Ertekin. Maternal and neonatal outcomes of borderline hyperglycemia during pregnancy diagnosed with abnormal screening test[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(6): 882-887.
No Suggested Reading articles found!